Literature DB >> 32648891

Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease Outbreaks.

Lee Kennedy-Shaffer, Marc Lipsitch.   

Abstract

Randomized controlled trials are crucial for the evaluation of interventions such as vaccinations, but the design and analysis of these studies during infectious disease outbreaks is complicated by statistical, ethical, and logistical factors. Attempts to resolve these complexities have led to the proposal of a variety of trial designs, including individual randomization and several types of cluster randomization designs: parallel-arm, ring vaccination, and stepped wedge designs. Because of the strong time trends present in infectious disease incidence, however, methods generally used to analyze stepped wedge trials might not perform well in these settings. Using simulated outbreaks, we evaluated various designs and analysis methods, including recently proposed methods for analyzing stepped wedge trials, to determine the statistical properties of these methods. While new methods for analyzing stepped wedge trials can provide some improvement over previous methods, we find that they still lag behind parallel-arm cluster-randomized trials and individually randomized trials in achieving adequate power to detect intervention effects. We also find that these methods are highly sensitive to the weighting of effect estimates across time periods. Despite the value of new methods, stepped wedge trials still have statistical disadvantages compared with other trial designs in epidemic settings.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cluster-randomized trials; epidemics; permutation tests; simulation; stepped wedge trials; synthetic control; vaccine trials

Mesh:

Year:  2020        PMID: 32648891      PMCID: PMC7604531          DOI: 10.1093/aje/kwaa141

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

Review 1.  Design and analysis of stepped wedge cluster randomized trials.

Authors:  Michael A Hussey; James P Hughes
Journal:  Contemp Clin Trials       Date:  2006-07-07       Impact factor: 2.226

2.  Robust inference for the stepped wedge design.

Authors:  James P Hughes; Patrick J Heagerty; Fan Xia; Yuqi Ren
Journal:  Biometrics       Date:  2019-11-01       Impact factor: 2.571

3.  Competing Effects of Indirect Protection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials.

Authors:  Matt D T Hitchings; Marc Lipsitch; Rui Wang; Steven E Bellan
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

4.  The use of permutation tests for the analysis of parallel and stepped-wedge cluster-randomized trials.

Authors:  Rui Wang; Victor De Gruttola
Journal:  Stat Med       Date:  2017-05-02       Impact factor: 2.373

5.  Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.

Authors:  Steven E Bellan; Juliet R C Pulliam; Carl A B Pearson; David Champredon; Spencer J Fox; Laura Skrip; Alison P Galvani; Manoj Gambhir; Ben A Lopman; Travis C Porco; Lauren Ancel Meyers; Jonathan Dushoff
Journal:  Lancet Infect Dis       Date:  2015-04-14       Impact factor: 25.071

6.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors:  Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal:  Lancet       Date:  2016-12-23       Impact factor: 79.321

7.  Bias and inference from misspecified mixed-effect models in stepped wedge trial analysis.

Authors:  Jennifer A Thompson; Katherine L Fielding; Calum Davey; Alexander M Aiken; James R Hargreaves; Richard J Hayes
Journal:  Stat Med       Date:  2017-05-28       Impact factor: 2.373

8.  Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection.

Authors:  Rebecca Kahn; Matt Hitchings; Rui Wang; Steven E Bellan; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

9.  An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.

Authors:  Steven E Bellan; Rosalind M Eggo; Pierre-Stéphane Gsell; Adam J Kucharski; Natalie E Dean; Richard Donohue; Matt Zook; W John Edmunds; Frank Odhiambo; Ira M Longini; Marc Brisson; Barbara E Mahon; Ana Maria Henao-Restrepo
Journal:  Vaccine       Date:  2019-06-24       Impact factor: 3.641

10.  Robust analysis of stepped wedge trials using cluster-level summaries within periods.

Authors:  J A Thompson; C Davey; K Fielding; J R Hargreaves; R J Hayes
Journal:  Stat Med       Date:  2018-04-10       Impact factor: 2.373

View more
  2 in total

1.  Much ado about something: a response to "COVID-19: underpowered randomised trials, or no randomised trials?"

Authors:  Noah A Haber; Sarah E Wieten; Emily R Smith; David Nunan
Journal:  Trials       Date:  2021-11-07       Impact factor: 2.279

2.  The required size of cluster randomized trials of nonpharmaceutical interventions in epidemic settings.

Authors:  Justin K Sheen; Johannes Haushofer; C Jessica E Metcalf; Lee Kennedy-Shaffer
Journal:  Stat Med       Date:  2022-03-07       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.